The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(1R,5R,7R)-3-benzyl-N-(3-hydroxypropyl)-2-oxo-6,8-dioxa-3-azabicyclo[3.2.1]octane-7-carboxamide ID: ALA606335
PubChem CID: 46229321
Max Phase: Preclinical
Molecular Formula: C16H20N2O5
Molecular Weight: 320.35
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C(NCCCO)[C@@H]1O[C@H]2CN(Cc3ccccc3)C(=O)[C@@H]1O2
Standard InChI: InChI=1S/C16H20N2O5/c19-8-4-7-17-15(20)13-14-16(21)18(10-12(22-13)23-14)9-11-5-2-1-3-6-11/h1-3,5-6,12-14,19H,4,7-10H2,(H,17,20)/t12-,13-,14-/m1/s1
Standard InChI Key: AOMGFTCNWPKOCP-MGPQQGTHSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
6.2290 -13.3612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0250 -13.1593 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6854 -13.6570 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.8900 -14.1154 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.7109 -14.4805 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2690 -14.8498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0794 -15.0092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4329 -14.8850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4435 -15.7099 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.1420 -14.4634 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.6833 -14.0542 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.0653 -14.1377 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6723 -14.8630 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8469 -14.8811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4539 -15.6056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8856 -16.3096 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7145 -16.2846 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1038 -15.5596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7734 -15.5094 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.8617 -14.8667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5708 -14.4450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0208 -12.3333 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
7.0750 -15.8333 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
11.2906 -14.8483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9997 -14.4267 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4 12 1 0
1 2 1 0
12 13 1 0
5 7 1 0
13 14 2 0
6 7 1 0
14 15 1 0
1 4 1 0
15 16 2 0
16 17 1 0
3 5 1 0
17 18 2 0
18 13 1 0
8 9 2 0
6 19 2 0
8 10 1 0
10 20 1 0
5 8 1 1
20 21 1 0
2 3 1 0
2 22 1 1
7 11 1 0
7 23 1 1
2 11 1 0
21 24 1 0
4 6 1 0
24 25 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 320.35Molecular Weight (Monoisotopic): 320.1372AlogP: -0.36#Rotatable Bonds: 6Polar Surface Area: 88.10Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.12CX Basic pKa: ┄CX LogP: -0.41CX LogD: -0.41Aromatic Rings: 1Heavy Atoms: 23QED Weighted: 0.70Np Likeness Score: -0.26
References 1. Trabocchi A, Mannino C, Machetti F, De Bernardis F, Arancia S, Cauda R, Cassone A, Guarna A.. (2010) Identification of inhibitors of drug-resistant Candida albicans strains from a library of bicyclic peptidomimetic compounds., 53 (6): [PMID:20184325 ] [10.1021/jm901734u ] 2. Calugi C, Guarna A, Trabocchi A.. (2014) Identification of constrained peptidomimetic chemotypes as HIV protease inhibitors., 84 [PMID:25042102 ] [10.1016/j.ejmech.2014.07.049 ]